Personalized vaccine + immunotherapy cuts advanced liver cancer in small trial.
There were no serious adverse reactions. The most common was mild injection site reactions.
This Geneos treatment is a DNA vaccine that delivers the genetic code of mutated proteins into cells through a small electrical impulse. Each vaccine can target up to 40 mutated genes.
Niranjan Sardesai, the president of Geneos said that despite the small size of this study, their results are important for the advancement of the field. “Our mechanism confirms every step, from vaccination to tumor reduction, required to explain the immunological basis for the observed clinical responses,” he said in the statement.
Comments are closed.